Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket



  • ZyVersa Therapeutics, Inc. ZVSA shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule 5635(c)(4).
  • Advent Technologies Holdings, Inc. ADN climbed 26.4% to $1.53 in pre-market trading. Hyundai Motor Company and Advent Technologies signed a joint development agreement following successful fuel cell technology assessment.
  • Boxed, Inc. BOXD gained 19% to $0.2140 in pre-market trading after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
  • YS Biopharma Co., Ltd. YS gained 16% to $8.11 in pre-market trading after dropping 8% on Wednesday.
  • China Jo-Jo Drugstores, Inc. CJJD shares rose 15.4% to $4.25 in pre-market trading after dropping more than 7% on Wednesday.
  • Agile Therapeutics, Inc. AGRX gained 14.3% to $0.3030 in pre-market trading following better-than-expected Q4 results.
  • Bellicum Pharmaceuticals, Inc. BLCM rose 13.8% to $0.33 in pre-market. Bellicum Pharmaceuticals shares fell over 8% on Wednesday after the company discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
  • Bird Global, Inc. BRDS shares rose 12.7% to $0.1360 in pre-market trading after dropping around 7% on Wednesday. Bird recently received additional funding, bringing total capital to $33 million this year.
  • Aziyo Biologics, Inc. AZYO rose 12.6% to $1.34 in pre-market trading after posting upbeat Q4 results.
  • Lion Group Holding Ltd. LGHL shares rose 12.1% to $0.2790 in pre-market trading after adding around 4% on Wednesday.


  • Minim, Inc. MINM fell 12.4% to $0.1375 in pre-market trading after gaining 17% on Wednesday. The company is expected to report Q4 results on March 29, 2023.
  • Heart Test Laboratories, Inc. HSCS shares dropped 8.7% to $0.95 in pre-market trading. Heart Test Laboratories, last week, posted a Q3 loss of $0.16 per share.
  • Coinbase Global, Inc. COIN fell 8.4% to $70.70 in pre-market trading after the company received a Wells Notice from the SEC alleging violations of federal securities laws in regards to the company's spot market and staking service.
  • VYNE Therapeutics Inc. VYNE fell 8.4% to $2.32 in pre-market after dropping more than 6% on Wednesday. VYNE Therapeutics recently posted a narrower-than-expected quarterly loss.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT fell 8% to $0.6716 in pre-market trading after gaining more than 13% on Wednesday.
  • Chewy, Inc. CHWY shares fell 6.6% to $35.26 in pre-market trading. Chewy reported better-than-expected earnings and sales results for its fourth quarter. However, the company's active customers came in at 20.4 million, down 1.2% from a year ago.
  • INVO Bioscience, Inc. INVO fell 6.4% to $0.7619 in pre-market trading after jumping over 28% on Wednesday. INVO recently signed binding agreements to acquire Wisconsin Fertility Institute.
  • Cidara Therapeutics, Inc. CDTX shares fell 6.3% to $1.78 in pre-market trading. Cidara Therapeutics and Melinta Therapeutics announced the FDA approval of REZZAYO for the treatment of candidemia and invasive candidiasis.
  • Sarcos Technology and Robotics Corporation STRC fell 6% to $0.40 in pre-market trading after gaining around 7% on Wednesday. Sarcos Technology recently posted upbeat quarterly results.
  • EZGO Technologies Ltd. EZGO fell 5% to $1.34 in pre-market trading after gaining over 33% on Wednesday.

Now Read This: Investor Fear Increases Following Fed's Rate Hike

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!